Categories: Patient Care

Pharmacies for COVID-19 care

Thu Jun 18, 2020

In clinical work and discovery science, the School takes on COVID-19

Tue May 12, 2020
The UCSF School of Pharmacy is moving quickly against the COVID-19 pandemic, applying a scientific mindset to challenges being raised during the crisis.

Update from the Dean: Eyeing a return

Fri May 8, 2020
Guglielmo
Elisabeth Fall

Dean B. Joseph Guglielmo, PharmD

Our COVID-19 response: Dean Guglielmo provides an update on School activities and a careful return to campus

Conversation on pharmacist COVID-19 testing with Marilyn Stebbins and Assemblywoman Cecilia Aguiar Curry

Thu May 7, 2020

California Poison Control sees jump in calls related to ingesting disinfectant after Trump’s comments

Thu Apr 30, 2020

Recovered virus patient says she tested positive for 50 days

Thu Apr 30, 2020

First Yolo County resident speaks about COVID-19 diagnosis, recovery

Thu Apr 30, 2020

My COVID-19 journey

Thu Apr 16, 2020
Stebbins
As we absorb the daily news of the COVID-19 pandemic, most of us—especially in California where an order to shelter in place was declared early on by Governor Gavin Newsom—have little first-hand knowledge of what it’s like to be a COVID-19 patient in the midst of the pandemic. Marilyn Stebbins,...

PharmD students organize PPE drives for hospitals to fight COVID-19

Thu Apr 9, 2020
PharmD students and pharmacy staff in front of pharmacy

UCSF PharmD students partnered with TIN Rx, a pharmacy in the Castro District of San Francisco, to collect PPE during the COVID-19 shelter-in-place. From the right: Adriana Gardner, Class of 2022; Leena Dolle, Class of 2021; Marianne Duran, Class of 2022; and three employees of TIN Rx.

Student pharmacists collect protective gear for front-line health care providers during the pandemic.

FDA, academia, and industry join forces to shepherd new therapies to patients

Thu Jan 23, 2020
Giacomini
Noah Berger

Kathy Giacomini, PhD, is co-director of UCSF-Stanford CERSI.

UCSF-Stanford CERSI brings together scientists, industry, and government regulators to get new therapies to patients sooner.

Pages